Bowhead Specialty (BOW) Projected to Post Quarterly Earnings on Tuesday

Bowhead Specialty (NYSE:BOW) is projected to post its Q3 2025 results before the market opens on Tuesday, November 4th. Analysts expect Bowhead Specialty to post earnings of $0.42 per share and revenue of $144.01 million for the quarter. Individuals can check the company’s upcoming Q3 2025 earningsummary page for the latest details on the call scheduled for Tuesday, November 4, 2025 at 8:30 AM ET.

Bowhead Specialty (NYSE:BOW) last posted its quarterly earnings data on Monday, August 26th. The company reported $0.27 earnings per share for the quarter. The company had revenue of $65.45 million during the quarter. Bowhead Specialty had a net margin of 10.05% and a return on equity of 13.25%. On average, analysts expect Bowhead Specialty to post $1 EPS for the current fiscal year and $2 EPS for the next fiscal year.

Bowhead Specialty Stock Performance

NYSE:BOW opened at $23.99 on Monday. The company has a fifty day moving average of $27.45 and a two-hundred day moving average of $32.88. The stock has a market capitalization of $786.23 million, a PE ratio of 16.32 and a beta of -0.92. Bowhead Specialty has a fifty-two week low of $23.50 and a fifty-two week high of $42.29.

Analysts Set New Price Targets

A number of equities analysts have weighed in on the stock. JMP Securities reduced their price objective on shares of Bowhead Specialty from $43.00 to $40.00 and set a “market outperform” rating for the company in a research report on Tuesday, October 14th. Piper Sandler reduced their target price on shares of Bowhead Specialty from $38.00 to $33.00 and set an “overweight” rating for the company in a research report on Thursday, October 2nd. JPMorgan Chase & Co. reduced their target price on shares of Bowhead Specialty from $39.00 to $33.00 and set a “neutral” rating for the company in a research report on Thursday, October 9th. Morgan Stanley reduced their target price on shares of Bowhead Specialty from $34.00 to $31.00 and set an “equal weight” rating for the company in a research report on Tuesday, October 7th. Finally, Zacks Research upgraded shares of Bowhead Specialty from a “strong sell” rating to a “hold” rating in a research report on Friday, August 15th. Five research analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $35.67.

Insider Transactions at Bowhead Specialty

In related news, Director Matthew Botein sold 2,000,000 shares of the company’s stock in a transaction dated Friday, August 8th. The shares were sold at an average price of $30.66, for a total value of $61,320,000.00. Following the completion of the sale, the director owned 8,968,445 shares of the company’s stock, valued at approximately $274,972,523.70. This represents a 18.23% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. Also, Director Gallatin Point Capital Llc sold 2,000,000 shares of the company’s stock in a transaction dated Friday, August 8th. The shares were sold at an average price of $30.66, for a total transaction of $61,320,000.00. Following the completion of the sale, the director directly owned 8,968,445 shares of the company’s stock, valued at $274,972,523.70. This represents a 18.23% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure.

Institutional Inflows and Outflows

Several hedge funds have recently bought and sold shares of BOW. Royal Bank of Canada boosted its stake in Bowhead Specialty by 112.7% during the first quarter. Royal Bank of Canada now owns 5,406 shares of the company’s stock worth $219,000 after buying an additional 2,864 shares during the period. AQR Capital Management LLC purchased a new position in Bowhead Specialty during the first quarter worth about $430,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its stake in Bowhead Specialty by 42.5% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 9,389 shares of the company’s stock worth $382,000 after buying an additional 2,802 shares during the period. Millennium Management LLC boosted its stake in Bowhead Specialty by 75.8% during the first quarter. Millennium Management LLC now owns 250,277 shares of the company’s stock worth $10,174,000 after buying an additional 107,896 shares during the period. Finally, NewEdge Advisors LLC purchased a new position in Bowhead Specialty during the first quarter worth about $206,000.

Bowhead Specialty Company Profile

Bowhead Specialty Holdings Inc provides specialty property and casualty insurance products in the United States. It underwrites casualty insurance solutions for risks in the construction, distribution, heavy manufacturing, real estate, and hospitality segments; professional liability insurance solutions for financial institutions, private and public directors and officers liability insurance, errors and omissions liability insurance, and cyber segments; and healthcare solutions for hospitals, senior care providers, managed care organizations, miscellaneous medical facilities, and healthcare management liability segments.